Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Cell And Gene Therapy Clinical Trials Market Size study, by Phase (Phase I, II, III, IV), By Indication (Oncology, CNS, Cardiology, Musculoskeletal, Infectious Diseases, Dermatology, Others)and Regional Forecasts 2022-2028

  • BIZ4983425
  • 200 Pages
  • July 2022
  • Healthcare
Download Sample    Get Discount   
 
Global Cell And Gene Therapy Clinical Trials Market is valued approximately USD 7.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.6 % over the forecast period 2022-2028. The rise in R&D investment, increased patient demand for new therapeutics, and expanding interest in cell and gene therapies for cancer therapy are driving the market. Cell and gene therapy (CGT) is a new frontier in the treatment of many severe illnesses, including uncommon genetic abnormalities and malignancies. It symbolizes a new era of innovation in the life sciences business. The COVID-19 pandemic decreased the number of gene therapy clinical trials in the early 2020s since most research was aimed at treating and diagnosing COVID-19. According to world Health Organization,, the percentage of gene therapy clinical studies grew dramatically in 2021 compared to previous years, as many researchers are now devoting their emphasis to gene therapy because of its promise in treating cancer and other uncommon disorders. This trend is projected to increase market growth over the next several years. CGT medicines had an R&D success rate of 11 percent from Phase I to commercialization between 2008 and 2018, compared to 8.2 percent for small-molecule compounds. The quantity and sophistication of the enterprises entering the market are expanding significantly. Small biotech businesses were among the early movers in this field. There was a lot of interest in the main biopharma companies. The vast majority of multinational pharmaceutical corporations are currently investing in CGT. For example, Novartis said in December 2021 that it had reached an acquisition deal with Gyroscope Therapeutics, an eye gene therapy business. However, stringent compliance regulations limit market growth over the projection period of 2022-2028.

The key regions considered for the Global Cell And Gene Therapy Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. This is due to a favourable regulatory environment, particularly in the United States. The FDA in the United States has designed a collaborative regulatory method for CGTs that includes early and consistent involvement with the sponsor, as well as unique regulatory designations that are useful for many CGTs. Furthermore, the regulatory clearance procedure in the United States is improving and becoming more beneficial to vendors producing CGT goods. During the projection period, Asia Pacific is expected to grow at the quickest CAGR. On the Asia Pacific area, a growing number of biotechnology enterprises are focusing in regenerative therapies. Furthermore, with the continued expansion of medical tourism destinations such as Thailand, Singapore, and India, the area is expected to maintain its position as the core of cell research and therapy.

Major market player included in this report are:

IQVIA

ICON Plc

Laboratory Corporation of America Holdings

Charles River Laboratories International, Inc

PAREXEL International Corp.

Syneos Health

Medpace Holdings, Inc.

PPD Inc.

Novotech

Veristat, LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Phase:

Phase I

Phase II

Phase III

Phase IV

By Indication:

Oncology

CNS

Cardiology

Musculoskeletal

Infectious Diseases

Dermatology

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Cell And Gene Therapy Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Cell And Gene Therapy Clinical Trials Market, by Region, 2020-2028 (USD Billion)

1.2.2. Cell And Gene Therapy Clinical Trials Market, by Phase, 2020-2028 (USD Billion)

1.2.3. Cell And Gene Therapy Clinical Trials Market, by Indication, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Cell And Gene Therapy Clinical Trials Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Cell And Gene Therapy Clinical Trials Market Dynamics

3.1. Cell And Gene Therapy Clinical Trials Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increase in R&D funding

3.1.1.2. Growing interest in cell and gene therapies for cancer treatment

3.1.2. Market Challenges

3.1.2.1. Stringent compliance regulations

3.1.3. Market Opportunities

3.1.3.1. Rising patient demand for innovative therapies

Chapter 4. Global Cell And Gene Therapy Clinical Trials Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cell And Gene Therapy Clinical Trials Market, by Phase

6.1. Market Snapshot

6.2. Global Cell And Gene Therapy Clinical Trials Market by Phase, Performance - Potential Analysis

6.3. Global Cell And Gene Therapy Clinical Trials Market Estimates & Forecasts by Phase 2018-2028 (USD Billion)

6.4. Cell And Gene Therapy Clinical Trials Market, Sub Segment Analysis

6.4.1. Phase I

6.4.2. Phase II

6.4.3. Phase III

6.4.4. Phase IV

Chapter 7. Global Cell And Gene Therapy Clinical Trials Market, by Indication

7.1. Market Snapshot

7.2. Global Cell And Gene Therapy Clinical Trials Market by Indication, Performance - Potential Analysis

7.3. Global Cell And Gene Therapy Clinical Trials Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)

7.4. Cell And Gene Therapy Clinical Trials Market, Sub Segment Analysis

7.4.1. Oncology

7.4.2. CNS

7.4.3. Cardiology

7.4.4. Musculoskeletal

7.4.5. Infectious Diseases

7.4.6. Dermatology

7.4.7. Others

Chapter 8. Global Cell And Gene Therapy Clinical Trials Market, Regional Analysis

8.1. Cell And Gene Therapy Clinical Trials Market, Regional Market Snapshot

8.2. North America Cell And Gene Therapy Clinical Trials Market

8.2.1. U.S. Cell And Gene Therapy Clinical Trials Market

8.2.1.1. Phase breakdown estimates & forecasts, 2018-2028

8.2.1.2. Indication breakdown estimates & forecasts, 2018-2028

8.2.2. Canada Cell And Gene Therapy Clinical Trials Market

8.3. Europe Cell And Gene Therapy Clinical Trials Market Snapshot

8.3.1. U.K. Cell And Gene Therapy Clinical Trials Market

8.3.2. Germany Cell And Gene Therapy Clinical Trials Market

8.3.3. France Cell And Gene Therapy Clinical Trials Market

8.3.4. Spain Cell And Gene Therapy Clinical Trials Market

8.3.5. Italy Cell And Gene Therapy Clinical Trials Market

8.3.6. Rest of Europe Cell And Gene Therapy Clinical Trials Market

8.4. Asia-Pacific Cell And Gene Therapy Clinical Trials Market Snapshot

8.4.1. China Cell And Gene Therapy Clinical Trials Market

8.4.2. India Cell And Gene Therapy Clinical Trials Market

8.4.3. Japan Cell And Gene Therapy Clinical Trials Market

8.4.4. Australia Cell And Gene Therapy Clinical Trials Market

8.4.5. South Korea Cell And Gene Therapy Clinical Trials Market

8.4.6. Rest of Asia Pacific Cell And Gene Therapy Clinical Trials Market

8.5. Latin America Cell And Gene Therapy Clinical Trials Market Snapshot

8.5.1. Brazil Cell And Gene Therapy Clinical Trials Market

8.5.2. Mexico Cell And Gene Therapy Clinical Trials Market

8.6. Rest of The World Cell And Gene Therapy Clinical Trials Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. IQVIA

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Phase Summary

9.2.1.5. Recent Developments

9.2.2. ICON Plc

9.2.3. Laboratory Corporation of America Holdings

9.2.4. Charles River Laboratories International, Inc

9.2.5. PAREXEL International Corp.

9.2.6. Syneos Health

9.2.7. Medpace Holdings, Inc.

9.2.8. PPD Inc.

9.2.9. Novotech

9.2.10. Veristat, LLC

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Cell And Gene Therapy Clinical Trials Market, report scope

TABLE 2. Global Cell And Gene Therapy Clinical Trials Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global Cell And Gene Therapy Clinical Trials Market estimates & forecasts by Phase 2018-2028 (USD Billion)

TABLE 4. Global Cell And Gene Therapy Clinical Trials Market estimates & forecasts by Indication 2018-2028 (USD Billion)

TABLE 5. Global Cell And Gene Therapy Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 6. Global Cell And Gene Therapy Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 7. Global Cell And Gene Therapy Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global Cell And Gene Therapy Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global Cell And Gene Therapy Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global Cell And Gene Therapy Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global Cell And Gene Therapy Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global Cell And Gene Therapy Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global Cell And Gene Therapy Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global Cell And Gene Therapy Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. U.S. Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. U.S. Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 17. U.S. Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 18. Canada Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 19. Canada Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 20. Canada Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. UK Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 22. UK Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 23. UK Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. Germany Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 25. Germany Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 26. Germany Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. RoE Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 28. RoE Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 29. RoE Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. China Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 31. China Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 32. China Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. India Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 34. India Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 35. India Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. Japan Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 37. Japan Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 38. Japan Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. RoAPAC Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 40. RoAPAC Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 41. RoAPAC Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. Brazil Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 43. Brazil Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 44. Brazil Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Mexico Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 46. Mexico Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 47. Mexico Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. RoLA Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 49. RoLA Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 50. RoLA Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. Row Cell And Gene Therapy Clinical Trials Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 52. Row Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 53. Row Cell And Gene Therapy Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Cell And Gene Therapy Clinical Trials Market

TABLE 55. List of primary sources, used in the study of global Cell And Gene Therapy Clinical Trials Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research